• Superior Biologics
Coherus and Superior Biologics Announce National Distribution Agreement for YUSIMRY™
- First formal distribution agreement for YUSIMRY™, a biosimilar of Humira®, at $995 per carton (two 40mg/0.8 mL autoinjectors) representing a discount of more than 85% compared to Humira®

Superior Biologics

Superior Biologics specializes in intravenous immunoglobin (IVIG) and Factor for hemophilic patients.  In addition, we support a wide range of infusion therapies for diseases in neurology, oncology, gastroenterology, rheumatology and dermatology.

Our unmatched track record for meeting patients’ needs has led to high levels of customer retention and allowed Superior Biologics to grow into a national provider. Superior Biologics has eight licensed pharmacies, six accredited pharmacies, five nursing agencies, and is licensed to dispense therapies in all 50 states and the District of Columbia.

Please visit https://superiorbiologics.com/about/ to learn more.